ACERUS Gross Profit

ASPCF -  USA Stock  

USD 0.02  0.01  33.33%

ACERUS PHARMACEUTICALS CORP fundamentals help investors to digest information that contributes to ACERUS PHARMACEUTICALS's financial success or failures. It also enables traders to predict the movement of ACERUS OTC Stock. This fundamental analysis module provides a way for investors to measures ACERUS PHARMACEUTICALS's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ACERUS PHARMACEUTICALS otc stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ACERUS Gross Profit 

 
Refresh

ACERUS Gross Profit Analysis

ACERUS PHARMACEUTICALS's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit 
 = 
Revenue 
-  
Cost of Revenue 
More About Gross Profit | All Equity Analysis

Current ACERUS PHARMACEUTICALS Gross Profit

    
  (929 K)  
Most of ACERUS PHARMACEUTICALS's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ACERUS PHARMACEUTICALS CORP is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Compare to competition

According to the company disclosure, ACERUS PHARMACEUTICALS CORP reported (929,000) of gross profit. This is 100.04% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The gross profit for all United States stocks is 100.0% higher than that of the company.

ACERUS Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ACERUS PHARMACEUTICALS's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of ACERUS PHARMACEUTICALS could also be used in its relative valuation, which is a method of valuing ACERUS PHARMACEUTICALS by comparing valuation metrics of similar companies.
ACERUS PHARMACEUTICALS is currently under evaluation in gross profit category among related companies.

ACERUS Fundamentals

About ACERUS PHARMACEUTICALS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ACERUS PHARMACEUTICALS CORP's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACERUS PHARMACEUTICALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACERUS PHARMACEUTICALS CORP based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

ACERUS PHARMACEUTICALS Investors Sentiment

The influence of ACERUS PHARMACEUTICALS's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ACERUS. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ACERUS PHARMACEUTICALS in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ACERUS PHARMACEUTICALS's short interest history, or implied volatility extrapolated from ACERUS PHARMACEUTICALS options trading.

Current Sentiment - ASPCF

ACERUS PHARMACEUTICALS Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in ACERUS PHARMACEUTICALS CORP. What is your sentiment towards investing in ACERUS PHARMACEUTICALS CORP? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Pair Trading with ACERUS PHARMACEUTICALS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACERUS PHARMACEUTICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACERUS PHARMACEUTICALS will appreciate offsetting losses from the drop in the long position's value.

ACERUS PHARMACEUTICALS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for ACERUS PHARMACEUTICALS and Merck Kgaa Dm. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to ACERUS PHARMACEUTICALS Piotroski F Score and ACERUS PHARMACEUTICALS Altman Z Score analysis. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Is ACERUS PHARMACEUTICALS's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACERUS PHARMACEUTICALS. If investors know ACERUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACERUS PHARMACEUTICALS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.